National Health Act 1953 - Determination under subsection 85B(1) (No. PB 48 of 2006) - Legislation

Determination under subsection 85B (1) (No. PB 48 of 2006)

as amended

made under the

National Health Act 1953

This compilation was prepared on 1 February 2007
taking into account amendments up to No. PB 8 of 2007

Prepared by the Office of Legislative Drafting and Publishing,
Attorney-General’s Department, Canberra

Pharmaceutical Benefits

Determination under subsection 85B (1)

No. PB 48 of 2006 [see Note 1]

This Determination commences on 1 December 2006.
Determination No. PB 41 of 2006 under subsection 85B(1) of the National Health Act 1953 made on 21 September 2006 with effect from 1 October 2006 is repealed.
In this Determination “authority prescription” means a prescription which directs the supply of a pharmaceutical benefit and is a prescription authorised in accordance with paragraph 12 of the determinations made under sections 85, 85A and 88 of the Act.
Section 85B of the Act applies in relation to each of the brands of the pharmaceutical benefits specified in Part A of the Schedule to this Determination (referred to in this Determination as “the Schedule”).
For the purposes of paragraph 85B(1)(c) of the Act, the quantity or number of units that is relevant for the purpose of determining an amount referred to in paragraph 85B (1) (d) or 85B(1)(e) of the Act in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the quantity or number of units specified in Part B of the Schedule in relation to the brand of the pharmaceutical benefit.
For the purposes of paragraph 85B(1)(d) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part C of the Schedule in relation to the brand of the pharmaceutical benefit.
For the purposes of paragraph 85B(1)(e) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the price claimed by the manufacturer as the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part D of the Schedule in relation to the brand of the pharmaceutical benefit.

8. The name of the manufacturer or the names of manufacturers denoted in accordance with the following table by letters appearing in the column headed “Brand” in Part A of the Schedule in relation to a pharmaceutical benefit specified in that Part of the Schedule is or are the brand or brands of the pharmaceutical benefit referred to in paragraphs 4, 5, 6 and 7:

Letters

Manufacturer's Name

Letters

Manufacturer's Name

AB	Abbott Australasia Pty Ltd
AG	Allergan Australia Pty Ltd
AL	Alphapharm Medical A Division of Alphapharm Pty Limited
AP	AstraZeneca Pty Ltd
AQ	Alcon Laboratories (Australia) Pty Ltd
AS	Aspen Pharmacare Australia Pty Ltd
AV	Aventis Pharma Pty Limited
BN	Bayer Australia Limited
BP	British Pharmaceuticals
BQ	Bristol-Myers Squibb Pharmaceuticals A Division of Bristol-Myers Squibb Australia Pty Ltd
BX	Baxter Healthcare Pty Limited
BY	Boehringer Ingelheim Pty Limited
CS	CSL Limited
DT	DermaTech Laboratories Pty Ltd
FR	Charles E. Frosst Division of Merck Sharp & Dohme (Australia) Pty Ltd
GC	GlaxoSmithKline Consumer Healthcare
GK	GlaxoSmithKline Australia Pty Ltd
JC	Janssen-Cilag Pty Ltd
LU	Lundbeck Australia Pty Ltd
LY	Eli Lilly Australia Pty Limited
MK	Merck Sharp & Dohme (Australia) Pty Ltd
ML	Marion Division of Aventis Pharma Pty Limited
MM	3M Pharmaceuticals Australia Pty Ltd
MQ	Merck Pharmaceuticals
MX	Mayne Pharma Pty Ltd
NM	Novartis Medicines A Division of Novartis Pharmaceuticals Australia Pty Ltd
NV	Novartis Pharmaceuticals Australia Pty Ltd
OR	Organon (Australia) Pty Limited
PC	Pfizer Consumer Healthcare Pty Ltd
PF	Pfizer Pty Limited
PH	Pharmacia Australia Pty Limited
RO	Roche Products Pty Ltd
SC	Schering Pty Ltd Australian Subsidiary of Schering AG, Berlin
SE	Servier Laboratories (Aust.) Pty Ltd
SG	Serono Australia Pty Ltd
SI	Sigma Pharmaceuticals Pty Ltd
SM	Solvay Pharmaceuticals Division of Solvay Biosciences Pty Ltd
SU	Sauter Laboratories (Aust.) Pty Ltd
SW	Sanofi-Synthelabo Australia Pty Limited
SZ	Sandoz Pty Ltd
UC	UCB Pharma A Division of UCB Australia Pty Ltd
VT	Valeant Pharmaceuticals Australasia Pty Ltd
WY	Wyeth Pharmaceuticals Division of Wyeth Australia Pty Limited

Aciclovir	Tablet 200 mg	GK	25	38.25	40.88
		GK	90	139.97	143.86
	Tablet 800 mg	GK	35	169.57	171.47
		GK	120	562.55	569.46
Alendronate Sodium	Tablet equivalent to 70 mg alendronic acid	MK	4	42.85	43.60
Allopurinol	Tablet 100 mg	SI	200	7.85	10.06
	Tablet 300 mg	SI	60	4.64	6.72
Alprazolam	Tablet 250 micrograms	PH	50	3.62	4.57
	Tablet 500 micrograms	PH	50	5.86	6.88
	Tablet 1 mg	PH	50	10.21	11.41
	Tablet 2 mg	PH	50	15.81	17.26
Aluminium Hydroxide - Dried with Magnesium Hydroxide	Tablet 200 mg-200 mg Oral suspension 200 mg-200 mg per 5 mL, 500 mL	PC PC	100 1	3.49 3.49	3.67 3.63
Amiodarone Hydrochloride	Tablet 100 mg	SW	30	10.00	10.88
	Tablet 200 mg	SW	30	17.76	18.64
Amlodipine Besylate	Tablet equivalent to 5 mg amlodipine (unless supplied on an authority prescription)	PF	30	13.86	17.92
	Tablet equivalent to 10 mg amlodipine (unless supplied on an authority prescription)	PF	30	24.39	30.28
Amoxycillin Trihydrate	Tablet equivalent to 1 g amoxycillin	SZ GK	14 14	5.06 5.06	6.42 6.42
	Capsule equivalent to 250 mg amoxycillin	GK	20	2.47	3.38
	Capsule equivalent to 500 mg amoxycillin	GK	20	4.91	5.82
Amoxycillin Trihydrate with Potassium Clavulanate	Tablet equivalent to 500 mg amoxycillin-125 mg clavulanic acid	GK	10	6.65	7.55
	Tablet equivalent to 875 mg amoxycillin-125 mg clavulanic acid	GK	10	9.48	10.66
Amoxycillin Trihydrate with Potassium Clavulanate and Water - Purified BP	Powder for oral suspension equivalent to 125 mg amoxycillin-31.25 mg clavulanic acid per 5 mL, 75 mL	GK	1	4.09	4.96
	Powder for oral suspension equivalent to 400 mg amoxycillin-57 mg clavulanic acid per 5 mL, 60 mL	GK	1	5.84	6.73
Amoxycillin Trihydrate with Water - Purified BP	Powder for paediatric oral drops equivalent to 100 mg amoxycillin per mL, 20 mL (unless supplied on an authority prescription)	GK	1	3.68	4.21
	Powder for oral suspension equivalent to 125 mg amoxycillin per 5 mL, 100 mL	GK	1	2.20	3.31
	Powder for oral suspension equivalent to 250 mg amoxycillin per 5 mL, 100 mL	GK	1	3.17	4.09
Aspirin	Tablet 100 mg	MX	112	1.41	2.61
Atenolol	Tablet 50 mg	AP	30	4.46	7.69
Azathioprine	Tablet 25 mg	GK	100	35.66	37.04
	Tablet 50 mg	GK	100	60.71	62.02
Baclofen	Tablet 10 mg	NV	100	29.74	32.37
	Tablet 25 mg	NV	100	65.05	67.69
Betamethasone Valerate	Cream equivalent to 200 micrograms betamethasone per g, 100 g	SI	1	3.76	6.49
	Cream equivalent to 500 micrograms betamethasone per g, 15 g	SI	1	1.89	3.58
	Ointment equivalent to 500 micrograms betamethasone per g, 15 g	SI	1	1.89	3.58
Betaxolol Hydrochloride	Eye drops, solution, equivalent to 5 mg betaxolol per mL, 5 mL	AQ	1	7.19	8.96
Bisacodyl	Suppositories 10 mg, 10	BY	1	4.57	4.91
Bleomycin Sulfate with any determined brand of Sodium Chloride Injection	Powder for injection 15,000 I.U. (with required solvent)	MX BQ SI	1 10 10	47.66 476.63 476.63	90.54 979.29 905.38
Brimonidine Tartrate	Eye drops 2 mg per mL, 5 mL	AG	1	12.93	14.47
Brinzolamide	Eye drops 10 mg per mL, 5 mL	AQ	1	12.93	13.82
Bromocriptine Mesylate	Tablet equivalent to 2.5 mg bromocriptine	NV NV	30 60	12.67 25.32	15.25 27.97
	Capsule equivalent to 5 mg bromocriptine	NV	60	49.79	52.44
	Capsule equivalent to 10 mg bromocriptine	NV	100	178.33	181.24
Bupropion Hydrochloride	Tablet 150 mg (sustained release)	GK GK	30 90	65.71 150.38	66.50 151.17
Captopril	Tablet 12.5 mg	BQ	90	11.89	14.13
	Tablet 25 mg	BQ	90	17.21	19.45
	Tablet 50 mg	BQ	90	33.95	36.19
Carbamazepine	Tablet 100 mg	NV	200	14.75	17.48
	Tablet 200 mg	NV	200	27.57	30.57
Carbomer 980	Ocular lubricating gel 2 mg per g, 10 g	NV	1	3.63	4.52
Cefaclor Monohydrate	Tablet (sustained release) equivalent to 375 mg cefaclor	AS	10	7.51	10.15
Cefaclor Monohydrate with Water - Purified BP	Powder for oral suspension equivalent to 125 mg cefaclor per 5 mL, 100 mL	AS	1	5.28	7.59
	Powder for oral suspension equivalent to 250 mg cefaclor per 5 mL, 75 mL	AS	1	5.65	8.04
Cefotaxime Sodium	Powder for injection equivalent to 1 g cefotaxime	SZ	1	1.88	4.28
	Powder for injection equivalent to 2 g cefotaxime	SZ	1	3.48	7.90
Cephalexin	Capsule 250 mg (anhydrous)	AS	20	2.81	4.98
	Capsule 500 mg (anhydrous)	AS	20	5.04	7.62
Cephalexin with Water - Purified BP	Granules for oral suspension 125 mg per 5 mL, 100 mL	AS	1	3.35	5.60
	Granules for oral suspension 250 mg per 5 mL, 100 mL	AS	1	4.97	7.54
Cephalothin Sodium	Powder for injection equivalent to 1 g cephalothin	AS	10	34.15	34.41
Cephazolin Sodium	Powder for injection equivalent to 1 g cephazolin	AS	10	55.76	57.96
Cimetidine	Tablet 200 mg	GK	120	17.35	19.62
	Tablet 400 mg	GK	60	17.35	19.62
Ciprofloxacin Hydrochloride	Tablet equivalent to 250 mg ciprofloxacin	BN	14	23.08	24.76
	Tablet equivalent to 500 mg ciprofloxacin	BN	14	45.10	46.78
	Tablet equivalent to 750 mg ciprofloxacin	BN	14	67.97	69.64
	Eye drops equivalent to 3 mg ciprofloxacin per mL, 5 mL	AQ	1	10.89	11.99
Citalopram Hydrobromide	Tablet equivalent to 20 mg citalopram	LU	28	19.16	21.97
Clarithromycin	Tablet 250 mg	AB	14	7.25	9.53
Clindamycin Hydrochloride	Capsule equivalent to 150 mg clindamycin	PH	25	12.33	13.61
Clomiphene Citrate	Tablet 50 mg	AV	10	30.93	34.21
		SG	10	30.93	31.09
Clomipramine Hydrochloride	Tablet 25 mg	NV	50	12.07	15.04
Clonazepam	Tablet 500 micrograms	RO	100	7.99	10.07
	Tablet 2 mg	RO	100	15.02	17.38
Codeine Phosphate with Paracetamol	Tablet 30 mg-500 mg	SW	20	1.92	3.59
Colchicine	Tablet 500 micrograms	AS	100	4.00	4.81
Cyclosporin	Capsule 25 mg	NV	30	44.76	45.82
	Capsule 50 mg	NV	30	93.12	94.27
	Capsule 100 mg	NV	30	189.73	190.89
Cyproterone Acetate	Tablet 50 mg	SC	20	55.76	59.93
		SC	50	122.20	124.20
	Tablet 100 mg	SC	50	197.98	199.99
Dexamethasone Sodium Metasulfobenzoate with Framycetin Sulfate and Gramicidin	Ear drops 500 micrograms (dexamethasone)-5 mg-50 micrograms per mL, 8 mL	AV	1	2.08	3.64
Diazepam	Tablet 2 mg	RO	50	1.80	2.95
		SU	50	1.80	2.59
	Tablet 5 mg	RO	50	2.00	3.16
		SU	50	2.00	2.83
Diclofenac Sodium	Tablet 25 mg (enteric coated)	NV	50	3.85	5.30
	Tablet 50 mg (enteric coated)	NV	50	5.37	8.18
Digoxin	Tablet 62.5 micrograms	SI	200	3.31	4.89
	Tablet 250 micrograms	SI	100	3.56	5.15
Diltiazem Hydrochloride	Tablet 60 mg	AV	90	12.98	15.30
	Capsule 180 mg (controlled delivery)	AV	30	14.40	16.72
	Capsule 240 mg (controlled delivery)	AV	30	19.44	21.76
	Capsule 360 mg (controlled delivery)	AV	30	25.49	28.31
Diphenoxylate Hydrochloride with Atropine Sulfate	Tablet 2.5 mg-25 micrograms	PH	20	1.71	3.33
Dothiepin Hydrochloride	Capsule 25 mg	AB	50	2.59	4.41
	Tablet 75 mg	AB	30	2.57	3.51
Doxepin Hydrochloride	Capsule equivalent to 10 mg doxepin	PF	50	2.22	3.84
	Capsule equivalent to 25 mg doxepin	PF	50	2.59	3.96
Doxycycline Hydrochloride	Tablet equivalent to 50 mg doxycycline	PF	25	4.23	5.68
	Capsule equivalent to 50 mg doxycycline (containing enteric coated pellets)	MX	25	4.23	5.74
	Tablet equivalent to 100 mg doxycycline	PF	7	2.37	3.76
	Capsule equivalent to 100 mg doxycycline (containing enteric coated pellets)	MX MX	7 21	2.37 7.07	3.70 9.49
Enalapril Maleate	Tablet 5 mg	MK	30	7.78	10.64
	Tablet 10 mg	FR	30	12.78	15.64
		MK	30	12.78	15.64
	Tablet 20 mg	FR	30	16.28	19.14
		MK	30	16.28	19.14
Erythromycin	Capsule 250 mg (containing enteric coated pellets)	MX	25	3.49	5.05
Erythromycin Ethyl Succinate	Tablet equivalent to 400 mg erythromycin	AB	25	3.20	5.75
Erythromycin Ethyl Succinate with Water - Purified BP	Powder for oral liquid equivalent to 200 mg erythromycin per 5 mL, 100 mL	AB	1	2.88	4.81
	Powder for oral liquid equivalent to 400 mg erythromycin per 5 mL, 100 mL	AB	1	4.31	5.86
Escitalopram Oxalate	Tablet equivalent to 10 mg escitalopram	LU	28	20.40	23.31
	Tablet equivalent to 20 mg escitalopram	LU	28	32.75	37.61
	Oral solution equivalent to 10 mg escitalopram per mL, 28 mL (unless supplied on an authority prescription)	LU	1	27.54	31.47
Famotidine	Tablet 20 mg	MK	60	12.75	17.67
	Tablet 40 mg	MK	30	12.75	17.67
Felodipine	Tablet 2.5 mg (extended release)	AP	30	9.35	12.09
	Tablet 5 mg (extended release)	AP	30	12.87	15.92
	Tablet 10 mg (extended release)	AP	30	23.04	27.28
Flecainide Acetate	Tablet 100 mg	MM	60	36.62	39.14
Flucloxacillin Magnesium with Water - Purified BP	Powder for oral suspension equivalent to 250 mg flucloxacillin per 5 mL, 100 mL	GK	1	8.53	8.61
Flucloxacillin Sodium	Capsule equivalent to 250 mg flucloxacillin	GK	24	5.83	6.24
	Capsule equivalent to 500 mg flucloxacillin	GK	24	12.20	12.72
Fluoxetine Hydrochloride	Tablet, dispersible, equivalent to 20 mg fluoxetine	LY	28	16.68	23.01
	Capsule equivalent to 20 mg fluoxetine	LY	28	16.68	23.01
Fluvastatin Sodium	Capsule equivalent to 20 mg fluvastatin	NM	28	18.50	19.41
	Capsule equivalent to 40 mg fluvastatin	NM	28	22.68	23.58
Fluvoxamine Maleate	Tablet 50 mg	SM	30	16.17	19.60
	Tablet 100 mg	SM	30	24.49	27.92
Frusemide	Tablet 20 mg	AV	50	1.51	2.00
	Tablet 40 mg	AV	100	2.74	3.72
Gemfibrozil	Tablet 600 mg	PF	60	30.83	33.90
Glibenclamide	Tablet 5 mg	AV	100	4.68	5.76
Gliclazide	Tablet 80 mg	SE	100	8.23	10.59
Glimepiride	Tablet 1 mg	AV	30	3.10	5.29
	Tablet 2 mg	AV	30	5.94	8.13
	Tablet 3 mg	AV	30	7.62	9.83
	Tablet 4 mg	AV	30	9.32	11.52
Glipizide	Tablet 5 mg	PH	100	4.77	8.38
Glyceryl Trinitrate	Tablets 600 micrograms, 100	SI	1	3.21	4.67
Hydrochlorothiazide with Amiloride Hydrochloride	Tablet 50 mg-5 mg	MK	50	2.82	4.32
Hydrocortisone Acetate	Cream 10 mg per g, 30 g	SI	1	1.61	3.29
	Cream 10 mg per g, 50 g	DT	1	2.02	2.09
		SI	1	2.02	3.71
	Ointment 10 mg per g, 30 g	SI	1	1.61	3.29
	Ointment 10 mg per g, 50 g	SI	1	2.02	3.71
Hypromellose	Eye drops 3 mg per mL, 15 mL	NV	1	3.63	5.28
Hypromellose with Carbomer 980	Ocular lubricating gel 3 mg-2 mg per g, 10 g	NV	1	3.63	5.28
Hypromellose 4500 with Dextran 70	Eye drops 3 mg-1 mg per mL, 15 mL	AQ	1	3.63	5.11
Imipramine Hydrochloride	Tablet 10 mg	NV	50	1.76	3.31
	Tablet 25 mg	NV	50	1.76	3.31
Indapamide Hemihydrate	Tablet 2.5 mg	SE	90	12.83	15.79
Indomethacin	Capsule 25 mg	MK	50	2.45	3.81
Ipratropium Bromide	Nebuliser solution 250 micrograms (anhydrous) in 1 mL single dose units, 30	BY	1	17.89	18.31
	Nebuliser solution 500 micrograms (anhydrous) in 1 mL single dose units, 30	BY	1	21.15	21.56
Iron Polymaltose Complex	Injection 100 mg (iron) in 2 mL ampoule	BX	5	41.90	42.98
Isosorbide Dinitrate	Tablet 10 mg	SI	100	3.29	4.91
Isosorbide Mononitrate	Tablet 60 mg (sustained release)	AP	30	7.49	10.07
	Tablet 120 mg (sustained release)	AP	30	17.76	20.49
Isotretinoin	Capsule 20 mg	RO	60	127.43	129.63
Ketoprofen	Capsule 200 mg (sustained release)	AV	28	9.32	11.09
Labetalol Hydrochloride	Tablet 100 mg	SI	100	7.85	10.34
	Tablet 200 mg	SI	100	13.64	16.26
Lactulose	Solution BP 3.34 g per 5 mL, 500 mL	SM	1	9.05	10.99
Lamotrigine	Tablet 5 mg	GK	56	11.97	12.85
	Tablet 25 mg	GK	56	26.64	27.53
	Tablet 50 mg	GK	56	44.43	45.31
	Tablet 100 mg	GK	56	74.02	74.90
	Tablet 200 mg	GK	56	124.35	125.23
Lansoprazole	Sachet containing granules for oral suspension, 30 mg per sachet (unless supplied on an authority prescription)	WY	28	28.41	31.71
Leflunomide	Tablet 10 mg	AV	30	82.60	83.66
	Tablet 20 mg	AV	30	125.76	126.83
Lercanidipine Hydrochloride	Tablet 10 mg (unless supplied on an authority prescription)	SM	30	17.28	18.25
	Tablet 20 mg (unless supplied on an authority prescription)	SM	30	28.34	31.70
Levetiracetam	Tablet 250 mg (unless supplied on an authority prescription)	UC	60	45.45	51.94
	Tablet 500 mg (unless supplied on an authority prescription)	UC	60	75.80	86.63
	Tablet 1 g (unless supplied on an authority prescription)	UC	60	126.28	144.32
Levodopa with Carbidopa	Tablet 100 mg-25 mg (anhydrous)	MK	100	30.05	34.80
	Tablet 250 mg-25 mg (anhydrous)	MK	100	37.05	39.87
Levonorgestrel with Ethinyloestradiol	Tablets 150 micrograms-30 micrograms, 21	SC	1	2.37	4.91
	Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets	SC WY	1 4	2.37 9.48	4.91 19.03
	Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets	SC WY	1 4	2.37 9.48	4.91 19.03
Lisinopril	Tablet 5 mg	AP	30	8.93	11.34
		MK	30	8.93	10.70
	Tablet 10 mg	AP	30	13.41	15.82
		MK	30	13.41	15.18
	Tablet 20 mg	AP	30	16.89	19.30
		MK	30	16.89	18.66
Loperamide Hydrochloride	Capsule 2 mg	JC	12	1.71	2.53
Medroxyprogesterone Acetate	Tablet 10 mg	PH	100	22.89	24.34
	Tablet 5 mg	PH PH	30 56	8.37 7.80	9.92 9.35
	Injection 150 mg in 1 mL vial	PH	1	7.30	10.25
Meloxicam	Tablet 7.5 mg	BY	30	15.91	17.54
	Tablet 15 mg	BY	30	23.20	24.83
Metformin Hydrochloride	Tablet 500 mg	AL	100	7.73	9.36
		MQ	100	7.73	9.01
	Tablet 850 mg	AL	60	7.73	9.63
		MQ	60	7.73	9.01
	Tablet 1 g	AL	90	13.46	15.10
Methyldopa	Tablet 250 mg	MK	100	6.70	9.29
Methylphenidate Hydrochloride	Tablet 10 mg	NV	100	7.88	9.47
Methylprednisolone Acetate	Injection 40 mg in 1 mL vial	PH	5	16.32	16.99
Metoclopramide Hydrochloride	Tablet 10 mg	VT	25	1.41	4.03
Metoprolol Tartrate	Tablet 50 mg	AP	100	5.12	8.07
		NV	100	5.12	7.62
	Tablet 100 mg	AP	60	6.50	9.45
		NV	60	6.50	9.01
Metronidazole	Tablet 400 mg	AV	21	4.18	6.00
	Tablet 200 mg	AV	21	1.78	3.53
Mianserin Hydrochloride	Tablet 10 mg	OR	50	8.45	10.21
	Tablet 20 mg	OR	50	17.84	20.47
Minocycline Hydrochloride	Tablet equivalent to 50 mg minocycline	SI	60	10.52	11.50
Mirtazapine	Tablet 30 mg	BP	30	24.25	26.23
		OR	30	24.25	47.74
	Tablet 45 mg	BP	30	40.42	42.41
Moclobemide	Tablet 150 mg	RO	60	14.31	15.15
	Tablet 300 mg	RO	60	27.54	29.23
Naproxen	Tablet 250 mg	RO	50	4.23	5.59
	Tablet 500 mg	RO	50	7.52	9.11
	Tablet 750 mg (sustained release)	RO	28	6.91	8.38
	Tablet 1 g (sustained release)	RO	28	9.21	10.77
Naproxen Sodium	Tablet 550 mg	RO	50	7.75	10.40
Nifedipine	Tablet 10 mg	BN	60	12.50	14.07
	Tablet 20 mg	BN	60	15.58	18.49
	Tablet 20 mg (controlled release) (unless supplied on an authority prescription)	BN	30	15.53	18.53
	Tablet 30 mg (controlled release)	BN	30	16.75	20.12
	Tablet 60 mg (controlled release)	BN	30	21.05	24.78
Nitrazepam	Tablet 5 mg	VT	25	1.70	3.48
Nizatidine	Capsule 150 mg	AS	60	16.36	21.16
	Capsule 300 mg	AS	30	16.36	21.16
Norethisterone	Tablets 350 micrograms, 28	PH	1	2.37	3.25
Norethisterone with Ethinyloestradiol	Tablets 500 micrograms-35 micrograms, 21	PH	1	2.37	4.12
	Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets	PH	1	2.37	4.12
	Tablets 1 mg-35 micrograms, 21	PH	1	2.37	4.12
	Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets	PH	1	2.37	4.12
	Pack containing 12 tablets 500 micrograms-35 micrograms, 9 tablets 1 mg-35 micrograms and 7 inert tablets	PH	1	2.37	4.12
Norfloxacin	Tablet 400 mg	MK	14	13.11	16.39
Oestradiol	Transdermal patches 3.28 mg, 8	NV	1	10.06	11.43
	Transdermal patches 4.33 mg, 8	NV	1	10.06	11.43
	Transdermal patches 6.57 mg, 8	NV	1	11.98	13.34
	Transdermal patches 8.66 mg, 8	NV	1	11.98	13.34
Omeprazole Magnesium	Tablet equivalent to 20 mg omeprazole	AP	30	26.57	29.07
Ondansetron	Wafer 4 mg	GK	4	30.51	31.13
		GK	10	76.26	76.89
	Wafer 8 mg	GK	4	47.79	48.42
		GK	10	119.47	120.09
Ondansetron Hydrochloride Dihydrate	Tablet equivalent to 4 mg ondansetron	GK GK	4 10	30.51 76.26	31.13 76.89
	Tablet equivalent to 8 mg ondansetron	GK GK	4 10	47.79 119.47	48.42 120.09
	I.V. injection equivalent to 4 mg ondansetron in 2 mL ampoule	GK	1	17.20	17.83
	I.V. injection equivalent to 8 mg ondansetron in 4 mL ampoule	GK	1	27.33	27.94
Oxazepam	Tablet 15 mg	SI	25	1.13	2.71
	Tablet 30 mg	SI	25	1.31	2.99
Paracetamol	Tablet 665 mg (modified release)	GC	96	2.97	5.12
Paraffin - Soft White with Paraffin - Liquid	Eye ointment, compound, 3.5 g Pack containing 2 tubes eye ointment, compound, 3.5 g	AQ AG	1 1	6.34 12.67	7.21 14.56
Paroxetine Hydrochloride	Tablet equivalent to 20 mg paroxetine	GK	30	22.09	23.09
Pemetrexed Disodium Heptahydrate	Powder for I.V. infusion equivalent to 500 mg pemetrexed, vial (unless supplied on an authority prescription)	LY	1	1,430.56	1,629.92
Phenoxymethylpenicillin Benzathine	Oral suspension equivalent to 125 mg phenoxymethylpenicillin per 5 mL, 100 mL	SI	1	3.34	4.16
	Oral suspension equivalent to 250 mg phenoxymethylpenicillin per 5 mL, 100 mL	SI	1	4.56	5.38
Pilocarpine Hydrochloride	Eye drops 10 mg per mL, 15 mL	AG	1	5.01	7.31
	Eye drops 20 mg per mL, 15 mL	AG	1	6.03	8.31
	Eye drops 40 mg per mL, 15 mL	AG	1	8.37	10.64
	Eye drops 60 mg per mL, 15 mL	AG	1	12.05	14.26
Pindolol	Tablet 5 mg	NV	100	5.87	8.34
	Tablet 15 mg	NV	50	8.45	10.90
Piperazine Oestrone Sulfate	Tablet 730 micrograms	PH	56	4.95	6.25
	Tablet 1.46 mg	PH	56	7.05	8.37
Piroxicam	Dispersible tablet 10 mg	PF	50	7.05	9.47
	Dispersible tablet 20 mg	PF	25	6.70	9.10
	Capsule 10 mg	PF	50	7.05	9.47
	Capsule 20 mg	PF	25	6.70	9.10
Polyvinyl Alcohol	Eye drops 14 mg per mL, 15 mL	AG	1	3.63	5.14
	Eye drops 30 mg per mL, 15 mL	AG	1	3.63	8.90
Potassium Chloride	Tablet 600 mg (sustained release)	NV	100	2.63	3.89
Potassium Chloride with Potassium Bicarbonate	Tablet, effervescent, 14 mmol K+ and 8 mmol Cl-	AS	60	5.37	7.68
Pravastatin Sodium	Tablet 10 mg	BQ	30	22.08	22.51
	Tablet 20 mg	BQ	30	35.08	35.52
	Tablet 40 mg	BQ	30	54.64	55.09
	Tablet 80 mg	BQ	30	83.76	84.21
Prazosin Hydrochloride	Tablet equivalent to 1 mg prazosin	PF	100	7.19	9.87
	Tablet equivalent to 2 mg prazosin	PF	100	9.86	12.63
	Tablet equivalent to 5 mg prazosin	PF	100	16.73	19.72
Prednisolone	Tablet 1 mg	AS	100	2.09	2.63
Prednisolone Sodium Phosphate	Oral solution equivalent to 5 mg prednisolone per mL, 30 mL	AS	1	7.06	8.68
Prednisone	Tablet 1 mg	AS	100	2.09	2.63
Prochlorperazine Maleate	Tablet 5 mg	AV	25	2.28	4.18
Propranolol Hydrochloride	Tablet 10 mg	AP	100	2.61	5.34
	Tablet 40 mg	AP	100	2.73	5.46
Quinapril Hydrochloride	Tablet equivalent to 5 mg quinapril	PF	30	9.53	9.97
	Tablet equivalent to 10 mg quinapril	PF	30	13.43	14.03
	Tablet equivalent to 20 mg quinapril	PF	30	16.56	17.45
Quinine Sulfate	Tablet 300 mg	AS	50	5.02	6.95
Ramipril	Tablet 1.25 mg	AV ML	30 30	6.35 6.35	9.08 7.26
	Tablet 2.5 mg	AV ML	30 30	9.28 9.28	12.01 10.61
	Tablet 5 mg	AV ML	30 30	11.64 11.64	14.36 13.30
	Capsule 10 mg	AV ML	30 30	20.54 20.54	23.47 23.47
	Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg (unless supplied on an authority prescription)	AV	1	18.09	20.67
Ranitidine Hydrochloride	Tablet equivalent to 150 mg ranitidine	GK	60	13.28	15.25
	Tablet, effervescent, equivalent to 150 mg ranitidine (unless supplied on an authority prescription)	GK	30	6.65	8.55
	Tablet equivalent to 300 mg ranitidine	GK	30	13.28	15.25
	Syrup equivalent to 150 mg ranitidine per 10 mL, 300 mL (unless supplied on an authority prescription)	GK	1	6.65	7.61
Roxithromycin	Tablet 150 mg	AV	10	6.18	8.38
	Tablet 300 mg	AV	5	6.18	8.38
Salbutamol Sulfate	Pressurised inhalation equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation)	GK MM	1 1	5.11 5.11	5.56 5.38
	Nebuliser solution equivalent to 2.5 mg salbutamol in 2.5 mL single dose units, 30	GK	1	8.29	9.26
	Nebuliser solution equivalent to 5 mg salbutamol in 2.5 mL single dose units, 30	GK	1	8.76	9.73
Sertraline Hydrochloride	Tablet equivalent to 50 mg sertraline	PF	30	21.14	21.63
	Tablet equivalent to 100 mg sertraline	PF	30	21.14	21.63
Simvastatin	Tablet 5 mg	FR	30	19.56	20.18
		MK	30	19.56	20.18
	Tablet 10 mg	FR	30	27.04	27.65
		MK	30	27.04	27.65
	Tablet 20 mg	FR	30	38.86	39.48
		MK	30	38.86	39.48
	Tablet 40 mg	FR	30	55.93	56.56
		MK	30	55.93	56.56
	Tablet 80 mg	FR	30	80.37	80.98
		MK	30	80.37	80.98
Sodium Valproate	Tablet 200 mg (enteric coated)	SW	100	13.91	14.49
	Tablet 500 mg (enteric coated)	SW	100	27.54	28.26
Sotalol Hydrochloride	Tablet 80 mg	BQ	60	10.85	12.31
	Tablet 160 mg	BQ	60	23.28	24.86
Spironolactone	Tablet 25 mg	PH	100	7.04	8.71
	Tablet 100 mg	PH	100	27.71	30.01
Sucralfate	Tablet equivalent to 1 g anhydrous sucralfate	AS	120	15.96	17.90
Sulfasalazine	Tablet 500 mg (enteric coated)	PH	100	23.48	24.21
Tamoxifen Citrate	Tablet equivalent to 10 mg tamoxifen	AP	30	18.82	19.78
	Tablet equivalent to 20 mg tamoxifen	AP	30	32.62	34.35
Temazepam	Tablet 10 mg	SI	25	1.70	3.31
Terbinafine Hydrochloride	Tablet equivalent to 250 mg terbinafine	NV	42	116.85	118.61
Thyroxine Sodium	Tablet equivalent to 50 micrograms anhydrous thyroxine sodium	SI	200	13.52	14.67
	Tablet equivalent to 100 micrograms anhydrous thyroxine sodium	SI	200	14.47	15.63
	Tablet equivalent to 200 micrograms anhydrous thyroxine sodium	SI	200	19.21	20.35
Ticlopidine Hydrochloride	Tablet 250 mg	RO	60	129.93	131.93
Timolol Maleate	Eye drops equivalent to 2.5 mg timolol per mL, 5 mL	FR	1	6.24	7.19
	Eye drops equivalent to 5 mg timolol per mL, 5 mL	FR	1	7.19	8.19
Tinidazole	Tablet 500 mg	PF	4	2.47	4.69
Topiramate	Tablet 25 mg (unless supplied on an authority prescription)	JC	60	30.31	32.42
	Tablet 50 mg (unless supplied on an authority prescription)	JC	60	50.53	52.64
	Tablet 100 mg (unless supplied on an authority prescription)	JC	60	84.19	86.56
	Tablet 200 mg (unless supplied on an authority prescription)	JC	60	141.43	143.81
	Capsule 15 mg (unless supplied on an authority prescription)	JC	60	21.83	23.94
	Capsule 25 mg (unless supplied on an authority prescription)	JC	60	30.31	32.42
	Capsule 50 mg (unless supplied on an authority prescription)	JC	60	50.53	52.64
Tramadol Hydrochloride	Capsule 50 mg	CS	20	3.17	4.49
	Tablet 100 mg (sustained release)	CS	20	8.63	10.39
	Tablet 150 mg (sustained release)	CS	20	11.63	13.39
	Tablet 200 mg (sustained release)	CS	20	14.16	15.91
Trandolapril	Capsule 500 micrograms	AB	28	7.59	8.95
	Capsule 1 mg	AB	28	12.06	13.43
	Capsule 2 mg	AB	28	13.06	14.43
Triamcinolone Acetonide	Cream 200 micrograms per g, 100 g	SI	1	3.76	5.21
	Ointment 200 micrograms per g, 100 g	SI	1	3.76	5.21
Triamcinolone Acetonide with Neomycin Sulfate, Gramicidin and Nystatin	Ear drops 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 7.5 mL	BQ	1	2.08	3.04
	Ear ointment 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 5 g	BQ	1	1.65	2.61
Trimethoprim	Tablet 300 mg	SI	7	2.39	3.59
Trimethoprim with Sulfamethoxazole	Tablet 160 mg-800 mg Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL	SI SI	10 1	3.44 3.05	4.72 4.74
Verapamil Hydrochloride	Tablet 40 mg	AB	100	5.90	6.78
	Tablet 80 mg	AB	100	10.48	11.36
	Tablet 180 mg (sustained release)	AB	30	8.46	11.09
	Tablet 240 mg (sustained release)	AB	30	11.28	13.91

Notes to the Determination under subsection 85B (1) (No. PB 48 of 2006)

Note 1

The Determination under subsection 85B (1) (No. PB 48 of 2006) (in force under subsection 85B (1) of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.

Table of Instruments

Title	Date of FRLI Registration	Date of commencement	Application, saving or transitional provisions
No. PB 48 of 2006	14 Nov 2006 (see F2006L03687)	1 Dec 2006
No. PB 5 of 2007	7 Dec 2006 (see F2006L03980)	1 Jan 2007	—
No. PB 8 of 2007	11 Jan 2007 (see F2007L00079)	1 Feb 2007	—

Table of Amendments

ad. = added or inserted am. = amended rep. = repealed rs. = repealed and substituted
Provision affected	How affected
The Schedule
The Schedule..........	am. Nos. PB 5 and PB 8 of 2007

National Health Act 1953 - Determination under subsection 85B(1) (No. PB 48 of 2006)

Administered by Department of Health, Disability and Ageing

Interactions

Legislation content

Interactions

Authorises

All Versions